Evidence map›Paper›PMID 39617770›Full record

ArticleScientific reports2024

Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure.

Ehsan Dezhakam, Roya Faraghi Vayghan, Sarina Dehghani, Taha Kafili-Hajlari, Abdolhossein Naseri, Mehdi Dadashpour, Balal Khalilzadeh, Gulsah Saydan Kanberoglu

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ehsan DezhakamDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Roya Faraghi VayghanDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Sarina DehghaniDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Taha Kafili-HajlariDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Abdolhossein NaseriDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran. ab.naseri@gmail.com.
Mehdi DadashpourDepartment of Medical Biotechnology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran. dadashpourmehdi1400@gmail.com.
Balal KhalilzadehStem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. balalkhalilzadeh@gmail.com.
Gulsah Saydan KanberogluDepartment of Chemistry, Faculty of Science, Yuzuncu Yil University, Van, 65080, Turkey.

Funding

Semnan University of Medical Sciences and Health Services 3821
6 · The paper itself

Abstract

Nowadays, rapid and facile diagnosis of cancer using user friendly processes has attracted much attention. In this regard, an electrochemical (EC) biosensor with high sensitivity was fabricated by merging MIL156 MOF@COF nanocomposite with Au nanoparticles for the detection of CA15-3. Herein, metal clusters of MIL-156 as a Metal organic frameworks (MOF) were coated by a crystalline covalent organic frameworks (COF) through covalent bonding and created core-shell-like structures. The active part of the working electrode was modified in two consecutive steps. First, MIL-156 MOF@COF and then Au nanoparticles were electrodeposited on the glassy carbon electrode (GCE). The porosity of nanocomposite has significantly increased the surface area and improved the conductivity. Au nanoparticles also form an acceptable substrate for bonding antibodies due to their high affinity with amino groups. In addition, Au nanoparticles amplify the EC signal of the biosensor with their undeniable conductivity. Nanocomposite was characterized with XRD, SEM, and EDAX techniques. To investigate the proposed biosensor, differential pulse voltammetry (DPV) was used as an analytical technique. The CA15-3 calibration provided a linear range between concentrations of 30 and 100 nU/mL, thus expressing the powerful diagnostic potential of the designed biosensor. Furthermore, the suggested biosensor has been used in serum samples and discriminate breast cancer sufferers from healthy individuals with high confidence levels.

Indexed as

Biosensing TechniquesBreast NeoplasmsElectrochemical TechniquesGoldMetal NanoparticlesMetal-Organic FrameworksMucin-1ElectrodesFemaleHumansLimit of DetectionNanocompositesNanostructuresGoldMetal-Organic FrameworksMUC1 protein, humanMucin-1Breast cancerCA15-3COFElectrochemical BiosensorMIL-156 MOF

Identifiers

PMID39617770
PMCPMC11609286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.